Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
AUTL compared with CLPT: revenue, margins and what each company keeps, and the suppliers and customers both name
AUTL
Autolus Therapeutics plc
Change
Mkt cap
Revenue
Revenue
CLPT
ClearPoint Neuro, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
AUTL
Autolus Therapeutics plc
vs
CLPT
ClearPoint Neuro, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Earnings history
Desk
News
Calendar
Saved
Search
Earnings history
last 4 reports each · paired by recency
Method
›
AUTL
No earnings history for AUTL.
CLPT
0 of 4
at or beyond implied
Report
implied
realized
× implied
Q3 FY26
±22.9%
▲
+1.23%
×0.05
Q2 FY26
±16.7%
▼
−16.29%
×0.98
May 14 '26
±8.5%
▲
+4.76%
×0.56
Q1 FY26
±15.6%
▼
−13.93%
×0.89
= implied
AUTL realized, solid
CLPT realized, hatched
One scale, both sides: full bar = 23%
× = |realized| ÷ implied
Source: market data
AUTL
Autolus Therapeutics plc
Change
1.29
▲
+1.98%
Mkt cap
$335.4M
Revenue
$46M
Q2 FY26
Revenue
$75M
FY25
CLPT
ClearPoint Neuro, Inc.
Change
8.55
▼
−1.67%
Regular session
Nov 6 '26
Mkt cap
$278.6M
Revenue
$12M
Q3 FY26
Revenue
$37M
FY25
vs
Compare
Regular session
Nov 6 '26
AUTL
Autolus Therapeutics plc
vs
CLPT
ClearPoint Neuro, Inc.
1.29
▲
+1.98%
Price
8.55
▼
−1.67%
$335.4M
Mkt cap
$278.6M
Q2 FY26
$46M
Revenue
$12M
Q3 FY26
FY25
$75M
Revenue
$37M
FY25
Change
Change
AUTL
1.29
▲
+1.98%
vs
CLPT
8.55
▼
−1.67%
Regular session
Nov 6 '26